Vanda Pharmaceuticals VNDA Income Statements

Conto economico

Quarter End	Mar 2023	Giu 2023	Set 2023	Dic 2023	Mar 2024	Giu 2024	Set 2024	Dic 2024
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Entrate totali	62,5M	46,06M	38,82M	45,27M	47,46M	50,47M	47,65M	53,19M
Reddito operativo	2M	-2,87M	-6M	-7,09M	-9,24M	-10,15M	-11M	-10,28M
Reddito ante imposte	5,53M	2,59M	-120k	-1,66M	-4,66M	-5,52M	-6,24M	-6,5M
Reddito netto	3,25M	1,52M	137k	-2,4M	-4,15M	-4,52M	-5,32M	-4,91M
Dividendi preferiti	0	0	0	0	0	0	0	0
Utile base per azione (EPS)	0	0	0	0	0	0	0	0
UTILE OPERATIVO	5,53M	2,59M	-120k	-1,66M	-4,66M	-5,52M	-6,24M	-6,5M
EBITDA	2,67M	-2,27M	-5,42M	-5,94M	-7,01M	-8,18M	-9,03M	-8,14M

Fine anno 31 Dicembre 2024	2017	2018	2019	2020	2021	2022	2023	2024
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Entrate totali	165,08M	193,12M	227,19M	248,17M	268,68M	254,38M	192,64M	198,77M
Reddito operativo	-16,9M	21,74M	22,81M	27,24M	42,17M	6,33M	-13,95M	-40,66M
Reddito ante imposte	-15,43M	25,35M	29,03M	31,66M	42,36M	11,3M	6,34M	-22,92M
Reddito netto	-15,57M	25,21M	115,55M	23,34M	33,15M	6,28M	2,51M	-18,9M
Dividendi preferiti	0	0	0	0	0	0	0	0
Utile base per azione (EPS)	-0.346	0.48	2.158	0.425	0.593	0.111	0.044	-0.324
UTILE OPERATIVO	-15,53M	25,85M	29,03M	31,66M	42,36M	11,3M	6,34M	-22,92M
EBITDA	-13,92M	24,69M	25,7M	30,1M	45,04M	9,06M	-10,94M	-32,36M